The PMHNP is considering using brexpiprazole for a patient w…

The PMHNP is considering using brexpiprazole for a patient with dementia experiencing severe agitation and psychosis. What is the most appropriate consideration for its use, given its pharmacological profile and the American Psychiatric Association’s guideline?